Generation of inhibitory DNA aptamers against human hepatocyte growth factor

DNA and Cell Biology

Volumn 24, Issue 10, 2005, Pages 624-633

  Saito, Takeshi ^a,b   Tomida, Mikio ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CYTOKINE; DNA; DOUBLE STRANDED DNA; SCATTER FACTOR; SINGLE STRANDED DNA;

ANGIOGENESIS; ARTICLE; BIOSENSOR; CANCER CELL CULTURE; CELL MIGRATION; CELL TYPE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BASE SEQUENCE; CELL MOVEMENT; CELLS, CULTURED; DNA; ENDOTHELIUM, VASCULAR; HEPATOCYTE GROWTH FACTOR; HUMANS; LIGANDS; MITOGENS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; SEQUENCE HOMOLOGY, NUCLEIC ACID; UMBILICAL VEINS;

EID: 26944460829     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.624     Document Type: Article

References (61)

1. ANDREOLA, M.L., PILEUR, F., CALMELS, C., VENTURA, M., TARRAGO-LITVAK, L., TOULME, J.J., and LITVAK, S. (2001). DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity. Biochemistry 40, 10087-10094.
2. BHARTI, A., MA, P.C., MAULIK, G., SINGH, R., KHAN, E., SKARIN, A.T., and SALGIA, R. (2004). Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res. 24, 1031-1038.
3. BOCK, L.C., GRIFFIN, L.C., LATHAM, J.A., VERMAAS, E.H., and TOOLE, J.J. (1992). Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564-566.
4. BOTTARO, D.P., RUBIN, J.S., FALETTO, D.L., CHAN, A.M., KMIECIK, T.E., VANDE WOUDE, G.F., and AARONSON, S.A. (1991). Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804.
5. BUSSOLINO, F., DI RENZO, M.F., ZICHE, M., BOCCHIETTO, E., OLIVERO, M., NALDINI, L., GAUDINO, G., TAMAGNONE, L., COFFER, A., and COMOGLIO, P.M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119, 629-641.
6. CAO, B., SU, Y., OSKARSSON, M., ZHAO, P., KORT, E.J., FISHER, R.J., WANG, L.M., and VANDE WOUDE, G.F. (2001). Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl. Acad. Sci. USA 98, 7443-7448.
7. DATE, K., MATSUMOTO, K., SHIMURA, H., TANAKA, M., and NAKAMURA, T. (1997). HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett. 420, 1-6.
8. DATE, I., TAKAGI, N., TAKAGI, K., KAGO, T., MATSUMOTO, K., NAKAMURA, T., and TAKEO, S. (2004). Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction. Biochem. Biophys. Res. Commun. 319, 1152-1158.
9. DAVIES, G., MASON, M.D., MARTIN, T.A., PARR, C., WATKINS, G., LANE, J., MATSUMOTO, K., NAKAMURA, T., and JIANG, W.G. (2003). The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo. Int. J. Cancer 106, 348-354.
10. DI RENZO, M.F., NARSIMHAN, R.P., OLIVERO, M., BRETTI, S., GIORDANO, S., MEDICO, E., GAGLIA, P., ZARA, P., and COMOGLIO, P.M. (1991). Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6, 1997-2003.
11. DONATE, L.E., GHERARDI, E., SRINIVASAN, N., SOWDHAMINI, R., APARICIO, S., and BLUNDELL, T.L. (1994). Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci. 3, 2378-2394.
12. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
13. ELLINGTON, A.D., and SZOSTAK, J.W. (1992). Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 355, 850-852.
14. FLOEGE, J., OSTENDORF, T., JANSSEN, U., BURG, M., RADEKE, H.H., VARGEESE, C., GILL, S.C., GREEN, L.S., and JANJIC, N. (1999). Novel approach to specific growth factor inhibition in vivo: Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am. J. Pathol. 154, 169-179.
15. GOHJI, K., NOMI, M., NIITANI, Y., KITAZAWA, S., FUJII, A., KATSUOKA, Y., and NAKAJIMA, M. (2000). Independent prognostic value of serum hepatocyte growth factor in bladder cancer. J. Clin. Oncol. 18, 2963-2971.
16. GOLD, L., POLISKY, B., UHLENBECK, O., and YARUS, M. (1995). Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64, 763-797.
17. GOLDEN, M.C., COLLINS, B.D., WILLIS, M.C., and KOCH, T.H. (2000). Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers. J. Biotechnol. 81, 167-178.
18. GREEN, L.S., JELLINEK, D., JENISON, R., OSTMAN, A., HELDIN, C.H., and JANJIC, N. (1996). Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 35, 14413-11424.
19. GREY, A.M., SCHOR, A.M., RUSHTON, G., ELLIS, I., and SCHOR, S.L. (1989). Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc. Natl. Acad. Sci. USA 86, 2438-2442.
20. HERMANN, T., and PATEL, D.J. (2000). Adaptive recognition by nucleic acid aptamers, Science 287, 820-825.
21. HUIZENGA, D.E., and SZOSTAK, J.W. (1995). A DNA aptamer that binds adenosine and ATP. Biochemistry 34, 656-665.
22. JAYASENA, S.D. (1999). Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 45, 1628-1650.
23. JELLINEK, D., LYNOTT, C. K., RIFKIN, D.B., and JANJIC, N. (1993). High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc. Natl. Acad. Sci. USA 90, 11227-11231.
24. JHAVERI, S., OLWIN, B., and ELLINGTON, A.D. (1998). In vitro selection of phosphorothiolated aptamers. Chem. Lett. 8, 2285-2290.
25. JIANG, W., HISCOX, S., MATSUMOTO, K., and NAKAMURA, T. (1999). Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit. Rev. Oncol. Hematol. 29, 209-248.
26. JING, N., LI, Y., XU, X., SHA, W., LI, P., FENG, L., and TWEARDY, D.J. (2003). Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells. DNA Cell Biol. 22, 685-696.
27. KUBIK, M.F., STEPHENS, A.W., SCHNEIDER, D., MARLAR, R.A., and TASSET, D. (1994). High-affinity RNA ligands to human alpha-thrombin. Nucleic Acids Res. 22, 2619-2626.
28. LIOTTA, L.A., MANDLER, R., MURANO, G., KATZ, D.A., GORDON, R.K., CHIANG, P.K., and SCHIFFMANN, E. (1986). Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. USA 83, 3302-3306.
29. MAEHARA, N., MATSUMOTO, K., KUBA, K., MIZUMOTO, K., TANAKA, M., and NAKAMURA, T. (2001). NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br. J. Cancer 84, 864-873.
30. MATSUMOTO, K., and NAKAMURA, T. (2003). NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci. 94, 321-327.
31. MIYAZAWA, K., TSUBOUCHI, H., NAKA, D., TAKAHASHI, K., OKIGAKI, M., ARAKAKI, N., NAKAYAMA, H., HIRONO, S., SAKIYAMA, O., TAKAHASHI, K., et al. (1989). Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163, 967-973.
32. MIZUNO, S., KUROSAWA, T., MATSUMOTO, K., MIZUNO-HORIKAWA, Y., OKAMOTO, M., and NAKAMURA, T. (1998). Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 101, 1827-1834.
33. MIZUNO, S., MATSUMOTO, K., and NAKAMURA, T. (2001). Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int. 59, 1304-1314.
34. MORI, T., OGURO, A., OHTSU, T., and NAKAMURA, Y. (2004). RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. Nucleic Acids Res. 32, 6120-6128.
35. MORISHITA, R., NAKAMURA, S., HAYASHI, S., TANIYAMA, Y., MORIGUCHI, A., NAGANO, T., TAIJI, M., NOGUCHI, H., TAKESHITA, S., MATSUMOTO, K., et al. (1999). Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33, 1379-1384.
36. NAKAMURA, T., NAWA, K., and ICHIHARA, A. (1984). Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122, 1450-1459.
37. NAKAMURA, T., NISHIZAWA, T., HAGIYA, M., SEKI, T., SHIMONISHI, M., SUGIMURA, A., TASHIRO, K., and SHIMIZU, S. (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443,
38. NAKAMURA, T., MIZUNO, S., MATSUMOTO, K., SAWA, Y., MATSUDA, H., and NAKAMURA, T. (2000). Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest. 106, 1511-1519.
39. NALDINI, L., VIGNA, E., NARSIMHAN, R.P., GAUDINO, G., ZARNEGAR, R., MICHALOPOULOS, G.K., and COMOGLIO, P.M. (1991). Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6, 501-504.
40. NIMJEE, S.M., RUSCONI, C.P., and SULLENGER, B.A. (2005). Aptamers: An emerging class of therapeutics. Annu. Rev. Med. 56, 555-583.
41. ODA, Y., SAKAMOTO, A., SAITO, T., KINUKAWA, N., IWAMOTO, Y., and TSUNEYOSHI. M. (2000). Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma. Hum. Pathol. 31, 185-192.
42. OKAHATA, Y., NIIKURA, K., SUGIURA, Y., SAWADA, M., and MORII, T. (1998). Kinetic studies of sequence-specific binding of GCN4-bZIP peptides to DNA strands immobilized on a 27-MHz quartz-crystal microbalance: Biochemistry 37, 5666-5672.
43. PIETRAS, K., OSTMAN, A., SJOQUIST, M., BUCHDUNGER, E., REED, R.K., HELDIN, C.H., and RUBIN, K. (2001). Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res. 61, 2929-2934.
44. RABIN, R., LOCHRIE, M., JANJIC, N., and GOLD, L. (2002). Patent [US-6344321 B1] Number Issue, 6344321.
45. RUBIN, J.S., BOTTARO, D.P., and AARONSON, S.A. (1993). Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim. Biophys. Acta 1155, 357-371.
46. RUCKMAN, J., GREEN, L S., BEESON. J., WAUGH, S., GILLETTE, W.L., HENNINGER, D.D., CLAESSON-WELSH, L., and JANJIC. N. (1998). 2′- Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). J. Biol. Chem. 273, 20556-20567.
47. SEIDEL, C., BORSET, M., TURESSON, I., ABILDGAARD, N., SUNDAN, A., and WAAGE, A. (1998). Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood 91, 806-812.
48. SIEGFRIED, J.M., WEISSFELD, L.A., SINGH-KAW, P., WEYANT, R J., TESTA, J.R., and LANDRENEAU, R.J. (1997). Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res. 57, 433-439.
49. STOKER, M., GHERARDI, E., PERRYMAN, M., and GRAY, J. (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327, 239-242.
50. TANIGUCHI, T., KITAMURA, M., ARAI, K., IWASAKI, Y., YAMAMOTO, Y., IGARI, A., and TOI, M. (1997). Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br. J. Cancer 75, 673-677.
51. TASSET, D.M., KUBIK, M.F., and STEINER, W. (1997). Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J. Mol. Biol. 272, 688-698.
52. TOI, M., TANIGUCHI, T., UENO, T., ASANO, M., FUNATA, N., SEKIGUCHI, K., IWANARI, H., and TOMINAGA, T. (1998). Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin. Cancer Res. 4, 659-664.
53. TOMIDA, M., and SAITO, T. (2004). The human hepatocyte growth factor (HGF) gene is transcriptionally activated by leukemia inhibitory factor through the Stat binding element. Oncogene 23, 679-686.
54. TOMIOKA, D., MAEHARA, N., KUBA, K., MIZUMOTO, K., TANAKA, M., MATSUMOTO, K., and NAKAMURA, T. (2001). Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Res. 61, 7518-7524.
55. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
56. UCHIDA, D., KAWAMATA, H., OMOTEHARA, F., NAKASHIRO, K., KIMURA-YANAGAWA. T., HINO, S., BEGUM, N.M., HOQUE, M.O., YOSHIDA, H., SATO, M., and FUJIMORI, T. (2001). Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int. J. Cancer 93, 489-496.
57. VAN BELLE, E., WITZENBICHLER, B., CHEN, D., SILVER, M., CHANG, L., SCHWALL, R., and ISNER, J.M. (1998). Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis. Circulation 97, 381-390.
58. WEIDNER, K.M., ARAKAKI, N., HARTMANN, G., VANDEKERCKHOVE, J., WEINGART, S., RIEDER, H., FONATSCH, C., TSUBOUCHI, H., HISHIDA, T., DAIKUHARA, Y., et al. (1991). Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 88, 7001-7005.
59. WEISS, S., PROSKE, D., NEUMANN, M., GROSCHUP, M.H., KRETZSCHMAR, H.A., FAMULOK, M., and WINNACKER, E.L. (1997). RNA aptamers specifically interact with the prion protein PrP. J. Virol. 71, 8790-8797.
60. YAMASHITA, J., OGAWA, M., YAMASHITA, S., NOMURA, K., KURAMOTO, M., SAISHOJI, T., and SHIN, S. (1994). Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 54, 1630-1633.
61. ZUKER, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acid Res. 31, 3406-3415.